Recent Finacing
Recent Raise
DJS Antibodies is an Oxford-based biotech that uses its proprietary HEPTAD platform to discover and industrialize monoclonal antibodies against GPCR and myeloid-driven inflammatory targets, advancing two lead programs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at DJS Antibodies.
